Ester

An ester is a carboxylic-acid tail covalently bonded via the 17β-hydroxyl group of a steroid nucleus. The modification is pharmacologically silent — esterified testosterone is inactive at the androgen receptor until plasma esterases hydrolyse the bond and release free hormone.

Chain length is the rate-limiting variable. More carbons means greater lipophilicity, slower diffusion out of the oil depot at the injection site, and slower esterase hydrolysis in serum.

Common esters, carbon count, half-life:

– Acetate (2C): 0.5–1 day — research-grade Trenbolone, oral preparations
– Propionate (3C): 0.8 days — Test P, Drostanolone Propionate, NPP short-form
– Phenylpropionate (9C, aromatic): 1.5 days — NPP, Test PP
– Enanthate (7C): 4.5 days — the reference ester for weekly AAS
– Cypionate (8C + cyclopentyl): 8 days — US-market equivalent of Enanthate
– Decanoate (10C): 15 days — Deca, Nandrolone Decanoate
– Undecylenate (11C, one double bond): 14 days — Boldenone U
– Undecanoate (11C saturated): 20–30 days — Testosterone U castor-oil depot

Clinical implications — design follows pharmacokinetics, not marketing:

Short esters produce aggressive peak-to-trough swings. On Propionate every 3 days, trough levels at 36 h post-injection can read 40% of peak. Sleep disturbance, mood lability, and acute HCT surges correlate with these swings. The tradeoff: clean tail at cycle-end, bloodwork normalises in days rather than weeks.

Long esters flatten the curve at the cost of PCT timing. Enanthate’s 4.5-day half-life mandates a 14-day wait before SERM initiation; Decanoate requires 21–28 days minimum. Attempting SERM-based HPTA recovery while esterified hormone is still hydrolysing is dose wasted.

Molecular weight correction: different esters contain different percentages of the parent hormone. Testosterone Enanthate is 72% testosterone by mass; Testosterone Propionate is 84%. A 100 mg dose of each delivers different active-hormone loads. Protocol calculations in the literature use active-hormone mg, not total ester mg — the difference matters at supraphysiological dosing.